Literature DB >> 2871174

Two bradykinin binding sites with picomolar affinities.

D C Manning, R Vavrek, J M Stewart, S H Snyder.   

Abstract

Bradykinin (BK) and related peptides exert a wide range of effects on several organ systems. We have attempted to sort out these effects by studying the binding interaction of [3H]BK at the membrane level with in vitro receptor binding techniques. High specific activity [3H]BK and an enzyme inhibitor "cocktail" has enabled us to label two BK binding sites with different affinity and peptide specificity in several guinea-pig tissues. In the guinea-pig ileum the high-affinity site has an equilibrium dissociation constant (Kd) for [3H]BK of 13 pM and a maximal number of binding sites of 8.3 pmol/g of tissue wet weight. The low-affinity guinea-pig ileum site displays a Kd of 910 pM, a maximum number of binding sites of 14 pmol/g of tissue wet weight and shows a greater selectivity for BK analogs over Lysyl-BK analogs. Two similar sites can also be discriminated in kidney and heart. The potencies of a series of BK analogs at the high-affinity guinea-pig ileum site correlate well with their potencies in contracting ileal smooth muscle. The binding of [3H]BK in the guinea-pig ileum is inhibited by physiological concentrations of monovalent and divalent cations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871174

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

1.  Bradykinin recognizes different molecular forms of the B2 kinin receptor in the presence and absence of guanine nucleotides.

Authors:  S A Mathis; L M Leeb-Lundberg
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.

Authors:  A Doble; D Girdlestone; O Piot; D Allam; J Betschart; A Boireau; A Dupuy; C Guérémy; J Ménager; J L Zundel
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

3.  Interleukin 1 amplifies receptor-mediated activation of phospholipase A2 in 3T3 fibroblasts.

Authors:  R M Burch; J R Connor; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Myotrophin/V-1 does not act as an extracellular signal to induce myocyte hypertrophy.

Authors:  Pascal Knuefermann; Shu-Ping Shi; Peter Chen; Yashushi Sakata; Georg Baumgarten; Natarajan Sivasubramanian
Journal:  Tex Heart Inst J       Date:  2006

5.  Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway.

Authors:  S Isami; H Kishikawa; E Araki; M Uehara; K Kaneko; T Shirotani; M Todaka; S Ura; S Motoyoshi; K Matsumoto; N Miyamura; M Shichiri
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

6.  Bradykinin analogues: differential agonist and antagonist activities suggesting multiple receptors.

Authors:  K M Braas; D C Manning; D C Perry; S H Snyder
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

7.  Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.

Authors:  L R Steranka; D C Manning; C J DeHaas; J W Ferkany; S A Borosky; J R Connor; R J Vavrek; J M Stewart; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  The neuropeptide bradykinin stimulates phosphoinositide turnover in HSDM1C1 cells: B2-antagonist-sensitive responses and receptor binding studies.

Authors:  N A Sharif; R L Whiting
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

9.  Pharmacological characterization of bradykinin receptors in canine cultured tracheal smooth muscle cells.

Authors:  C M Yang; S F Luo; H C Hsia
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin.

Authors:  D T Martins; D R Fior; C R Nakaie; C J Lindsey
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.